VIRVir Biotechnology, Inc.

$1B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$605,000-89.4% YoY

Gross Profit

$605,000100.0% margin

Operating Income

-$159M-26220.3% margin

Net Income

-$169M-27919.2% margin

EPS (Diluted)

$-1.32

QoQ Revenue Growth

+101.0%

Cash Flow

Operating Cash Flow

-$90M

Free Cash Flow

-$90M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$485M

Stockholders' Equity

$651M

Cash & Equivalents

$521M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$605,000	$6M	-89.4%
Gross Profit	$605,000	-$52M	+101.2%
Operating Income	-$159M	-$72M	-120.6%
Net Income	-$169M	-$77M	-118.7%

Revenue Segments

Contract Revenue

$605,000100%

VIR Q1 2021 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena